ATAD2 expression also correlated with MYC signaling in all three cancer types (R2 = 0.11, 0.21, and R2 = 0.31, respectively for breast cancers, glioblastomas, and ovarian cancers; p<0.001 in all cases), and was more strongly correlated with MYC signaling strength than MYC expression was (R2 = 0.10, p<0.001; R2 = 0.09, p<0.001; and R2 = 0.02, p = 0.003 in the three cancer types). The gene discussed is ATAD2; the disease is glioblastoma.